Skip to main content

Table 1 Baseline characteristics of PWUD in relation to the presence of HBV, anti-HCV and HIV (n = 253)

From: Seroprevalence of hepatitis B virus infection, anti-HCV antibodies and HIV and knowledge among people who use drugs attending methadone therapy clinic in Tanzania; a cross-sectional study

Variable

Total (n = 253)

HBV +(n = 9)

HBV – (n = 244)

P value

HCV + (n = 9)

HCV- (n = 244)

P value

HIV + (n = 32)

HIV – (n = 221)

P value

Sex

   

a

  

a

  

< 0.001

 Male

230 (90.9)

9 (3.9)

221(90.6)

 

9(3.9)

221(90.6)

 

20(62.5)

210(95.0)

 

 Female

23(9.1)

0

23(9.4)

 

0

23(9.4)

 

12(37.5)

11(4.9)

 

Age groups

          

 18–24

32 (12.7)

0

32(13.1)

a

0

32(13.1)

a

6(18.8)

26(11.8)

0.27

 25–30

96 (37.9)

0

96(36.3)

a

2(22.1)

94(38.5)

0.32

3(9.4)

93(42.1)

< 0.001

 31–35

51 (20.2)

3(33.3)

48(19.7)

0.32

2(22.2)

49(20.1)

0.88

7(21.9)

44(19.9)

0.79

 36–40

38(15.0)

4(44.4)

34(13.9)

0.01

4(14.4)

34(13.9)

0.01

8(25.0)

30(13.6)

0.09

 41–45

25(9.9)

1(11.1)

24(9.8)

0.89

1(11.1)

24(9.8)

0.89

6(18.8)

19(8.6)

0.07

 46–50

9(3.6)

1(11.1)

8(3.3)

0.21

0

9(3.7)

a

2(6.3)

7(3.2)

0.38

 > 50

2(0.8)

0

2(0.8)

a

0

2(0.8)

a

0

2(0.9)

a

Marital

   

0.51

  

0.95

  

0.02

 Single

143(56.5)

4(2.8)

139(56.9)

 

5(55.6)

138(56.6)

 

12(37.5)

131(59.3)

 

 Married/cohabiting

110(43.5)

5(55.6)

105(43.0)

0.46

4(44.4)

106(43.4)

 

20(62.5)

90(40.7)

 

Education

   

0.65

  

0.29

  

0.08

 Primary or below

180 (71.2)

7(77.8)

173(70.9)

 

5(55.6)

175(71.7)

 

27(84.4)

153(69.2)

 

 Secondary and above

73 (28.9)

2(22.2)

71(29.1)

 

4(44.4)

69(28.3)

 

5(15.6)

68(30.8)

 

Drug history

Types of drugs

   

0.78

  

0.78

  

0.88

  Opioids only

179(70.8)

6(66.7)

173(70.9)

 

6(66.7)

173(70.9)

 

23(71.9)

156(70.6)

 

  Opioids + other drugs

74(29.3)

3(33.3)

71(29.1)

 

3(33.3)

71(29.1)

 

9(28.1)

65(29.4)

 

Route

  Injection only

32(12.7)

3(33.3)

29(11.9)

0.05

2(22.2)

30(12.3)

0.58

3(9.4)

29(13.1)

0.55

  Snorting only

97(38.3)

0

97(39.8)

a

2(22.2)

95(38.9)

0.38

9(28.1)

88(39.8)

0.20

  Both

124(49.0)

6(66.7)

118(48.4)

0.28

5(55.6)

119(48.8)

0.69

20(62.5)

104(47.1)

0.10

Duration of drug use

 < 5 years

39(15.4)

0

39(15.9)

a

0

39(15.9)

a

3(9.4)

36(16.3)

0.56

 5–10 years

136(53.8)

4(44.4)

132(54.1)

0.57

4(44.4)

132(54.1)

0.56

15(46.9)

121(54.8)

0.40

 > 10 years

78(30.8)

5(55.6)

73(29.9)

0.60

5(55.6)

73(29.9)

0.10

14(43.8)

64(28.9)

0.09

  1. a Not computed because of zero observation